Go Pro
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
$8.30
-2.7%		$8.83
$3.30
▼
$11.06
$831.32M1.8604,190 shs842,348 shs
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$16.59
-4.8%		$17.30
$8.80
▼
$32.71
$783.72M3.37994,156 shs957,710 shs
InMode Ltd. stock logo
INMD
InMode
$14.77
-0.1%		$15.07
$12.72
▼
$16.74
$850.14M1.86440,202 shs824,753 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.01
-1.0%		$2.40
$0.80
▼
$3.57
$231.64M1.161.21 million shs635,779 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-2.70%-4.82%-9.49%-9.29%+72.20%
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-4.76%-16.72%-5.85%+14.18%-33.29%
InMode Ltd. stock logo
INMD
InMode
-0.14%-0.47%-2.44%+9.81%-1.66%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-0.99%+10.66%-5.64%+126.32%-12.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
$8.30
-2.7%		$8.83
$3.30
▼
$11.06
$831.32M1.8604,190 shs842,348 shs
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$16.59
-4.8%		$17.30
$8.80
▼
$32.71
$783.72M3.37994,156 shs957,710 shs
InMode Ltd. stock logo
INMD
InMode
$14.77
-0.1%		$15.07
$12.72
▼
$16.74
$850.14M1.86440,202 shs824,753 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.01
-1.0%		$2.40
$0.80
▼
$3.57
$231.64M1.161.21 million shs635,779 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-2.70%-4.82%-9.49%-9.29%+72.20%
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-4.76%-16.72%-5.85%+14.18%-33.29%
InMode Ltd. stock logo
INMD
InMode
-0.14%-0.47%-2.44%+9.81%-1.66%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-0.99%+10.66%-5.64%+126.32%-12.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
2.60
Moderate Buy$16.0092.77% Upside
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2.50
Moderate Buy$20.1021.16% Upside
InMode Ltd. stock logo
INMD
InMode
2.00
Hold$16.008.33% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.60
Moderate Buy$4.5049.50% Upside

Current Analyst Ratings Breakdown

Latest STIM, BBNX, AVR, and INMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/11/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
B Riley logo
B Riley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy
9/9/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$6.00
8/26/2026
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/21/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageMarket Perform
8/18/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/14/2026
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$15.00
8/11/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$5.00 ➝ $6.00
8/6/2026
InMode Ltd. stock logo
INMD
InMode
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
7/28/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$22.00
7/21/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
7/20/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$5.00
(Data available from 9/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
$1.91M423.52N/AN/A($0.01) per share-830.00
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$100.25M7.45N/AN/A$6.53 per share2.54
InMode Ltd. stock logo
INMD
InMode
$370.49M2.29$1.49 per share9.91$10.78 per share1.37
Neuronetics, Inc. stock logo
STIM
Neuronetics
$149.16M1.54N/AN/A$0.38 per share7.92
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-$94.14M-$1.95N/AN/AN/A-4,619.27%-77.69%-67.99%11/11/2026 (Estimated)
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$73.20M-$1.65N/AN/AN/A-61.31%-26.30%-23.25%N/A
InMode Ltd. stock logo
INMD
InMode
$93.83M$1.2312.01N/AN/A20.69%11.99%10.60%10/28/2026 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$39M-$0.44N/AN/AN/A-19.62%-125.11%-22.15%11/3/2026 (Estimated)

Latest STIM, BBNX, AVR, and INMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026 TU
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
-$0.2073-$0.30-$0.0927-$0.30$1.50 million$1.01 million
8/11/2026Q2 2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.1230-$0.05+$0.0730-$0.05$40.17 million$41.57 million
8/5/2026Q2 2026
InMode Ltd. stock logo
INMD
InMode
$0.3460$0.35+$0.0040$0.29$94.89 million$95.59 million
7/29/2026Q2 2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.62-$0.53+$0.09-$0.53N/A$32.01 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
N/AN/AN/AN/AN/A
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/AN/AN/AN/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
N/A
14.20
14.20
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
8.88
7.96
InMode Ltd. stock logo
INMD
InMode
N/A
8.18
7.28
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.84
1.88
1.69

Institutional Ownership

CompanyInstitutional Ownership
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
N/A
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
InMode Ltd. stock logo
INMD
InMode
68.04%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%

Insider Ownership

CompanyInsider Ownership
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
4.50%
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
5.30%
InMode Ltd. stock logo
INMD
InMode
6.92%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Anteris Technologies Global Corp. stock logo
AVR
Anteris Technologies Global
13897.46 million93.07 millionN/A
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
29444.99 million42.61 millionN/A
InMode Ltd. stock logo
INMD
InMode
48057.48 million53.50 millionOptionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18076.20 million69.80 millionOptionable

Recent News About These Companies

Neuronetics, Inc. (NASDAQ:STIM) Receives Average Recommendation of "Moderate Buy" from Brokerages
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-neuronetics-inc-nasdaq-stim-receives-average-recommendation-of-moderate-buy-from-brokerages-2026-09-11/
BTIG Research Reiterates Buy Rating for Neuronetics (NASDAQ:STIM)
September 11 at 1:54 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31015816
BTIG Research Reaffirms "Buy" Rating for Neuronetics (NASDAQ:STIM)
September 9 at 8:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-btig-research-reaffirms-buy-rating-for-neuronetics-nasdaq-stim-2026-09-09/
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
September 8 at 8:32 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/08/3357668/0/en/neurostar-advances-practice-innovation-with-first-ever-tms-integration-with-an-ehr-emr-system.html
BlackRock Inc. Invests $776,000 in Neuronetics, Inc. $STIM
September 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-blackrock-inc-invests-776000-in-neuronetics-inc-stim-2026-09-07/
18,540,488 Shares in Neuronetics, Inc. $STIM Purchased by Madryn Asset Management LP
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-18540488-shares-in-neuronetics-inc-stim-purchased-by-madryn-asset-management-lp-2026-08-29/
Neuronetics (STIM) Q2 2026 Earnings Call Transcript
August 18, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/neuronetics-stim-q2-2026-earnings-154322384.html
Neuronetics (NASDAQ:STIM) Major Shareholder Acquires 14,000 Shares of Stock
August 18, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-stim-insider-buying-and-selling-2026-08-18/
Neuronetics (NASDAQ:STIM) Major Shareholder Buys $44,240.00 in Stock
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/neuronetics-nasdaqstim-major-shareholder-buys-4424000-in-stock-2026-08-17/
Neuronetics, Inc. (STIM) Q2 FY2026 earnings call transcript
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/STIM/earnings/STIM-Q2-2026-earnings_call-660691.html
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ...
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/neuronetics-inc-stim-q2-2026-210214027.html
Neuronetics: Q2 Earnings Snapshot
August 11, 2026  |  wtop.comW
Neuronetics Reports Second Quarter 2026 Financial and Operating Results
August 11, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/neuronetics-reports-second-quarter-2026-financial-and-operating-results-1036440611
Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934722-neuronetics-inc-stim-q2-2026-earnings-call-transcript
Neuronetics narrows Q2 loss as Greenbrook growth drives 9% revenue increase
August 11, 2026  |  msn.comhttps://www.msn.com/en-us/money/economy/neuronetics-narrows-q2-loss-as-greenbrook-growth-drives-9-revenue-increase/ar-AA29RRR5
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates
August 11, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2972561/neuronetics-stim-reports-q2-loss-beats-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2972561
Neuronetics Reports Second Quarter 2026 Results, Highlights Revenue Growth and Improved Adjusted EBITDA
August 11, 2026  |  quiverquant.comQ
Malvern’s Neuronetics reaches deal with shareholder who pushed to break up company
August 5, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/malvern-s-neuronetics-reaches-deal-with-shareholder-who-pushed-to-break-up-company/ar-AA29olDT
Neuronetics and Jorey Chernett Announce Shared Vision
August 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/03/3337435/0/en/neuronetics-and-jorey-chernett-announce-shared-vision.html
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/31/3337067/0/en/neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
July 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/28/3334245/0/en/Neuronetics-to-Report-Second-Quarter-2026-Financial-and-Operating-Results-and-Host-Conference-Call.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
General Electric (GE) logo displayed on glass panel with wind turbines and solar panels in the background.
GE Vernova’s AI Power Boom Faces a Profit Test
By Peter Frank | August 12, 2026
Dutch Bros drive-thru location with windmill logo signage and cars in line at dusk.
Dutch Bros Sell-Off Creates a Growth Opportunity
By Peter Frank | September 1, 2026
Broadcom logo displayed on a computer chip embedded in a circuit board with glowing blue connections.
The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
By Leo Miller | September 3, 2026
CrowdStrike logo displayed on a dark panel with a red digital globe and cybersecurity icons in the background.
CrowdStrike’s “Mythos Moment” Tests the Bigger AI Security Trade
By Chris Markoch | August 28, 2026
Illuminated Pathward logo displayed on a wall in a corporate office reception area with glass doors.
Pathward’s Credit Scare Tests Its Comeback Story
By Peter Frank | August 25, 2026
Anteris Technologies Global stock logo

Anteris Technologies Global NASDAQ:AVR

$8.30 -0.23 (-2.70%)
Closing price 09/10/2026 04:00 PM Eastern
Extended Trading
$8.23 -0.07 (-0.89%)
As of 08:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Beta Bionics stock logo

Beta Bionics NASDAQ:BBNX

$16.59 -0.83 (-4.76%)
Closing price 09/10/2026 04:00 PM Eastern
Extended Trading
$16.67 +0.08 (+0.48%)
As of 08:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

InMode stock logo

InMode NASDAQ:INMD

$14.77 -0.02 (-0.14%)
Closing price 09/10/2026 04:00 PM Eastern
Extended Trading
$14.79 +0.02 (+0.16%)
As of 08:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$3.01 -0.03 (-0.99%)
Closing price 09/10/2026 04:00 PM Eastern
Extended Trading
$3.08 +0.07 (+2.33%)
As of 08:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas